{"id":15144,"date":"2024-05-09T09:01:16","date_gmt":"2024-05-09T08:01:16","guid":{"rendered":"https:\/\/www.adas.org.rs\/?p=15144"},"modified":"2025-11-19T11:24:17","modified_gmt":"2025-11-19T10:24:17","slug":"finalistkinja-vimbldona-suspendovana-zbog-dopinga-na-profesionalnoj-turneji","status":"publish","type":"post","link":"https:\/\/www.adas.org.rs\/en\/iz_medija\/2024\/05\/09\/finalistkinja-vimbldona-suspendovana-zbog-dopinga-na-profesionalnoj-turneji\/","title":{"rendered":"Wimbledon girls finalist suspended for doping on pro tour"},"content":{"rendered":"<p><\/p>\n<p>LONDON (AP) \u2014 Wimbledon girls finalist Nikola Bartunkova was provisionally suspended by the International Tennis Integrity Agency for doping on Thursday.<\/p>\n<p>The agency said the 18-year-old Czech player tested positive for the banned heart medication trimetazidine at tournaments in Trnava, Slovakia, and Maribor, Slovenia, in February and March, respectively.<\/p>\n<p>The medication, known as TMZ, also was found in high-profile positive tests given in 2021 by Russian figure skater Kamila Valieva and 23 Chinese swimmers who were preparing for the Tokyo Olympics.<\/p>\n<p>https:\/\/apnews.com\/article\/nikola-bartunkova-doping-tennis-6419290dbdedbb5d2486ccb122a92fa0<\/p>","protected":false},"excerpt":{"rendered":"<p>LONDON (AP) \u2014 Wimbledon girls finalist Nikola Bartunkova was provisionally suspended by the International Tennis Integrity Agency for doping on Thursday. The agency said the 18-year-old Czech player tested positive for the banned heart medication trimetazidine at tournaments in Trnava, Slovakia, and Maribor, Slovenia, in February and March, respectively. The medication, known as TMZ, also <a href=\"https:\/\/www.adas.org.rs\/en\/iz_medija\/2024\/05\/09\/finalistkinja-vimbldona-suspendovana-zbog-dopinga-na-profesionalnoj-turneji\/\" class=\"more-link\">&#8230;<span class=\"screen-reader-text\">  Wimbledon girls finalist suspended for doping on pro tour<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-15144","post","type-post","status-publish","format-standard","hentry","category-iz_medija"],"_links":{"self":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/comments?post=15144"}],"version-history":[{"count":3,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15144\/revisions"}],"predecessor-version":[{"id":16840,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15144\/revisions\/16840"}],"wp:attachment":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/media?parent=15144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/categories?post=15144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/tags?post=15144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}